Journal ArticleDOI
Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets
TLDR
LncRNAs are emerging as convenient and minimally invasive diagnostic/prognostic markers, and also as therapeutic target for the selective killing of cancer cells in patients.Abstract:
Because of high specificity and easy detection in the tissues, serum, plasma, urine and saliva, interest in exploring the potential of long non-coding RNAs (lncRNAs) in cancer patients continues to increase. LncRNAs have shown potential as a biomarker in the diagnosis and prognosis of bladder cancer, prostate cancer, gastric cancer, pancreatic cancer, breast cancer and many other cancer types. Some lncRNAs have also been used as adjunct to improve the specificity and sensitivity of existing biomarkers. The molecular tools such as RNA-seq, RNA-FISH, ic-SHAPE and quantitative real-time PCR have been used for examining the lncRNAs' potential. Some lncRNAs such as PCA3 is now routinely used in the clinic for the diagnosis of prostate cancer. Single nucleotide polymorphisms (SNPs) in lncRNAs can also be used as a predictor of cancer risk. Although ongoing studies continue to unravel the underlying mechanism, some lncRNAs have been used as therapeutic targets for the selective killing of cancer cells in patients. Thus lncRNAs are emerging as convenient and minimally invasive diagnostic/prognostic markers, and also as therapeutic target. Companies such as the Curna Inc., MiNA Therapeutics Ltd. and RaNA Therapeutics Inc. have been taking steps to develop lncRNA based strategies against cancer. In this review, we discuss the potential of lncRNAs as biomarkers and therapeutic targets in cancer patients.read more
Citations
More filters
Journal ArticleDOI
Biomarkers of gastric cancer: Current topics and future perspective.
Tasuku Matsuoka,Masakazu Yashiro +1 more
TL;DR: The current status and approaches in GC biomarker are summarized, which could be potentially used for early diagnosis, accurate prediction of therapeutic approaches and the future perspective based on the molecular classification and profiling is discussed.
Journal ArticleDOI
LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer
Gang Zhang,Shuwei Li,Jiafei Lu,Yuqiu Ge,Qiaoyan Wang,Gaoxiang Ma,Qinghong Zhao,Dongdong Wu,Weida Gong,Mulong Du,Haiyan Chu,Meilin Wang,Aihua Zhang,Zhengdong Zhang +13 more
TL;DR: MT1JP, a down-regulated lncRNA in GC, was associated with malignant tumor phenotypes and survival of GC, and it is suggested that MT1JP may act as a potential therapeutic target and prognosis biomarker for GC.
Journal ArticleDOI
Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.
Shruti Mishra,Sumit Singh Verma,Vipin Rai,Nikee Awasthee,Srinivas Chava,Kam M. Hui,Alan Prem Kumar,Kishore B. Challagundla,Gautam Sethi,Subash C. Gupta +9 more
TL;DR: How the modulation of lncRNAs by phytochemicals produce therapeutic effects on cancer and other chronic diseases is discussed in this review.
Journal ArticleDOI
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity.
Nicola Amodio,Maria Angelica Stamato,Giada Juli,Eugenio Morelli,Mariateresa Fulciniti,Martina Manzoni,Martina Manzoni,Elisa Taiana,Elisa Taiana,Luca Agnelli,Luca Agnelli,Maria Eugenia Gallo Cantafio,Enrica Romeo,Lavinia Raimondi,Daniele Caracciolo,Valeria Zuccalà,Marco Rossi,Antonino Neri,Antonino Neri,Nikhil C. Munshi,Nikhil C. Munshi,Pierosandro Tagliaferri,Pierfrancesco Tassone,Pierfrancesco Tassone +23 more
TL;DR: A crucial role of MALAT1 in the regulation of the proteasome machinery is demonstrated, and proof-of-concept that its targeting is a novel powerful option for the treatment of MM is provided.
Journal ArticleDOI
Long Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors.
Peixin Dong,Ying Xiong,Junming Yue,Sharon J.B. Hanley,Noriko Kobayashi,Yukiharu Todo,Hidemichi Watari +6 more
TL;DR: The latest insights into the expression pattern, biological roles and mechanisms underlying the function and regulation of NEAT1 in tumors are highlighted, and its clinical implication as a new diagnostic biomarker and an attractive therapeutic target for cancers is focused on.
References
More filters
Journal ArticleDOI
Long non-coding RNA lnc-MX1-1 is associated with poor clinical features and promotes cellular proliferation and invasiveness in prostate cancer
Chen-Yi Jiang,Yuan Gao,Xing-Jie Wang,Yuan Ruan,Xiao-Yu Bei,Xiaohai Wang,Yifeng Jing,Wei Zhao,Qi Jiang,Jia Li,Bang-Min Han,Shu-Jie Xia,Fu-Jun Zhao +12 more
TL;DR: There was a significant association between over-expression of lnc-MX1-1 and patients' clinical features such as PSA, Gleason score, metastasis, and recurrence free survival, and knockdown of l NCRNAs reduced both proliferation and invasiveness of LNCaP and 22Rv1 cells.
Journal ArticleDOI
Microarray profiling of bone marrow long non-coding RNA expression in Chinese pediatric acute myeloid leukemia patients.
Lan Cao,Peifang Xiao,Yan-Fang Tao,Shaoyan Hu,Jun Lu,Wenli Zhao,Zhi-Heng Li,Na-Na Wang,Jian Wang,Xing Feng,Yi-huan Chai,Jian Pan,Guixiong Gu +12 more
TL;DR: Dysregulated lncRNAs and mRNAs in pediatric AML versus normal controls are revealed that could form gene pathways to regulate cell cycle progression and immunoresponse that could serve as novel therapeutic targets and bbdiagnostic biomarkers in pediatricAML.
Journal ArticleDOI
Polymorphisms at long non-coding RNAs and prostate cancer risk in an eastern Chinese population
Dalong Cao,Chengyuan Gu,Yunping Zhu,Bo Dai,Hai Liang Zhang,Guo-wei Shi,Yi Jun Shen,Yunhui Zhu,Chun Guang Ma,Wenjun Xiao,Xiaojian Qin,Guowen Lin,Deyong Ye +12 more
TL;DR: It is suggested that lncRNA SNPs may contribute to prostate cancer risk in an eastern Chinese population and thus provide clues for new therapeutic targets of prostate cancer.
Journal ArticleDOI
Non-coding RNAs: could they be the answer?
TL;DR: The majority of the regions that do not clearly correspond to a 'gene' controlling certain traits might be ncRNAs or other regulatory transcripts that are still unknown and will need to be carefully examined in the future.